IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q2 2022 Holdings

Filed 2022-07-08 | 12 holdings | $5.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$3.3M16,00058.1%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$2.3M230,00041.2%
Utah MED Prods Inc(UTMD)COM917488108$7.4K86,0000.1%
LA Jolla Pharmaceutical Co(LJPC)COM503459604$4.0K1,265,0000.1%
Harmony Biosciences Hldgs in(HRMY)COM413197104$3.7K76,0000.1%
Cigna Corp New(CI)COM125523100$3.7K14,0000.1%
Gilead Sciences Inc(GILD)COM375558103$3.6K58,0000.1%
Bristol-Myers Squibb Co(BMY)COM110122108$3.4K44,0000.1%
Mckesson Corp(MCK)COM58155Q103$3.3K10,0000.1%
Viatris Inc(VTRS)COM92556V106$3.2K310,0000.1%
Kempharm Inc(ZVRA)COM NEW488445206$3.0K670,0000.1%
Opiant Pharmaceuticals IncCOM683750103$2.5K210,0000.0%